Kronos Bio, Inc.Kronos Bio, Inc.Kronos Bio, Inc.

Kronos Bio, Inc.

No trades
See on Supercharts

KRON fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
KRON has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company